Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). Flex Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D., recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D.
|Recent Press Releases||More >>|
FDA Clears Flex Pharma's FLX-787 to Commence US Phase 2 Trial in ALS Under IND
Flex Pharma Presents Human Efficacy Data on FLX-787 at the American Academy of Neurology Annual Meeting
Flex Pharma Names William K. McVicar, Ph.D. as President, Research & Development
|Upcoming Events||More >>|
|There are currently no events scheduled.|
|Data Provided by Thomson Reuters|